Radiation Therapy Oncology Group

Quick facts

Marketed products

• AA · Oncology
  Radiation therapy is a treatment that uses high doses of radiation to kill cancer cells.
• Biafine cream
• Eulexin · Other
• LHRH · Other

Phase 3 pipeline

• Anti-androgen
• CCNU · Oncology
  CCNU (lomustine) is a nitrosourea alkylating agent that cross-links DNA strands, preventing cell replication and inducing cancer cell death.
• concurrent temozolomide · Oncology
  Temozolomide is an alkylating agent that works by interfering with DNA replication in cancer cells.
• Sm-153 · Oncology
  Sm-153 is a radioactive isotope used for targeted radiation therapy.

Phase 2 pipeline

• adjuvant cisplatin
• adjuvant gemcitabine
• consolidation 5-fluorouracil
• Consolidation Carboplatin · Oncology
  Carboplatin works by interfering with DNA replication in cancer cells, leading to cell death.
• consolidation cisplatin
• consolidation gemcitabine
• Consolidation Paclitaxel
  Paclitaxel works by inhibiting cell division, thereby preventing cancer cells from multiplying.
• induction 5-fluorouracil
• Induction Carboplatin
• induction gemcitabine
• Induction Paclitaxel · Oncology
  Inhibits microtubule assembly by binding to tubulin
• Manuka honey in liquid form
• Manuka honey in lozenge form
• Samarium 153
• therapeutic melatonin

Phase 1 pipeline

• post-radiation temozolomide
• post-radiation therapy temozolomide
• radioprotection · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Radiation Therapy Oncology Group portfolio CI brief
• Radiation Therapy Oncology Group pipeline updates RSS